Dopamine Receptor Subtypes Differentially Regulate Autophagy.
Dongmei Wang1,2, Xinmiao Ji3, Juanjuan Liu4
1High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China. dongmeiwang@hmfl.ac.cn.
Dopamine receptors D2 and D3 promote autophagy, while D1 and D5 inhibit it. Ligands induce receptor degradation, involving AKT-mTOR and AMPK pathways, offering insights into neurodegenerative disease treatments.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Dopamine receptors' role in autophagy is not fully understood.
- Existing research suggests some subtypes influence autophagy, but mechanisms remain unclear.
Purpose of the Study:
- To investigate the specific functions and mechanisms of dopamine receptor subtypes in regulating autophagy.
- To elucidate the signaling pathways involved in dopamine receptor-mediated autophagy.
- To explore the relationship between dopamine receptor degradation and autophagy.
Main Methods:
- Investigated the effects of different dopamine receptor subtypes (D1-like and D2-like families) on autophagy.
- Examined the impact of endogenous ligands (dopamine and ammonia) on receptor behavior.
- Analyzed the involvement of AKT-mTOR and AMPK signaling pathways.
- Assessed the effect of autophagy perturbation on dopamine receptor D3 (DRD3) degradation and oligomerization.
Main Results:
- Dopamine receptors D2 and D3 act as positive regulators of autophagy.
- Dopamine receptors D1 and D5 function as negative regulators of autophagy.
- Dopamine and ammonia induce internalization and degradation of dopamine receptors.
- The AKT-mTOR and AMPK pathways are implicated in DRD3-regulated autophagy.
- Disrupting autophagy machinery inhibits DRD3 degradation and promotes DRD3 oligomer formation.
Conclusions:
- Dopamine receptors differentially regulate autophagy, with D2/D3 promoting and D1/D5 inhibiting the process.
- Receptor-ligand interactions influence dopamine receptor stability via autophagy.
- Signaling pathways like AKT-mTOR and AMPK are crucial in this regulation.
- Findings provide a basis for understanding neurodegenerative diseases linked to dopamine receptors and suggest potential therapeutic strategies involving autophagy or mTOR modulation.
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
GTPases and their Regulation
Large G-proteins,...


